8-K: Global Medical REIT Announces Third Quarter 2024 Financial Results, Completes $80.3 Million in Acquisitions

Sentiment:

Quarterly Report


Global Medical REIT reported its third quarter 2024 financial results, including a net income of $1.8 million, and completed $80.3 million in acquisitions of single-tenant medical real estate.

Delay expectedThe company expects to complete the acquisition of a five-property portfolio in two tranches during the first half of 2025, indicating a delay in the closing of the transaction.Rent commencement for the new lease at the Beaumont facility is expected in March or April 2025, a delay from the original lease.
Capital raiseThe company issued 1.2 million shares of its common stock through its ATM program at an average offering price of $9.95 per share, generating gross proceeds of $12.0 million.From October 1, 2024 through November 5, 2024, the Company did not issue any shares under its ATM program.
Worse than expectedNet income, FFO, and AFFO all decreased compared to the same period last year, indicating a decline in profitability.Rental revenue decreased by 3.7% year-over-year, suggesting a weakening in the company's core operations.

Summary

  • Global Medical REIT (GMRE) announced its financial results for the three and nine months ended September 30, 2024.
  • The company completed $80.3 million in acquisitions of single-tenant triple-net medical real estate year-to-date.
  • Net income attributable to common stockholders for the third quarter was $1.8 million, or $0.03 per diluted share, down from $3.1 million, or $0.05 per diluted share, in the same period last year.
  • Funds from Operations (FFO) was $13.7 million, or $0.19 per share, compared to $15.3 million, or $0.22 per share, in the prior year period.
  • Adjusted Funds from Operations (AFFO) was $15.3 million, or $0.22 per share, compared to $16.5 million, or $0.23 per share, in the prior year period.
  • Rental revenue for the third quarter decreased by 3.7% year-over-year to $34.2 million.
  • The company sold two medical facilities in Florida for a total of $12.1 million, resulting in a gain of $1.8 million.
  • Portfolio leased occupancy was 96.1% at September 30, 2024.
  • The company entered into a purchase agreement to acquire a five-property portfolio for $69.6 million at a 9.0% cap rate, expected to close in the first half of 2025.
  • Total debt outstanding was $628.9 million with a weighted average interest rate of 3.79% and a leverage ratio of 44.1%.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While the company is actively growing its portfolio through acquisitions, the financial results show a decline in profitability and revenue compared to the previous year. The company is also facing some tenant issues and delays in closing acquisitions.

Positives

  • The company successfully completed significant acquisitions, expanding its portfolio with high-quality medical real estate.
  • A new 15-year lease was secured for the Beaumont facility, mitigating the impact of the Steward Health Care bankruptcy.
  • The company has a strong portfolio occupancy rate of 96.1%.
  • The company has a weighted average rent escalation of 2.2% providing organic growth.
  • The company has a rent coverage ratio of 4.6 times.

Negatives

  • Net income attributable to common stockholders decreased to $1.8 million from $3.1 million in the prior year period.
  • Funds from Operations (FFO) decreased to $13.7 million from $15.3 million in the prior year period.
  • Adjusted Funds from Operations (AFFO) decreased to $15.3 million from $16.5 million in the prior year period.
  • Rental revenue decreased by 3.7% year-over-year to $34.2 million.
  • The company experienced a loss of $1.6 million on the sale of investment properties for the nine-month period.

Risks

  • The company's financial results were negatively impacted by changes in the portfolio and tenants placed on cash basis accounting.
  • The company is exposed to tenant risk, as demonstrated by the Steward Health Care bankruptcy.
  • The company's future acquisitions are subject to customary terms and conditions, and there is no assurance that they will close.
  • The company's debt carries a weighted average interest rate of 3.79% and a weighted average remaining term of 2.2 years, which could be impacted by interest rate fluctuations.
  • The company's leverage ratio is 44.1%, which could be a risk if the company's financial performance deteriorates.

Future Outlook

The company expects to complete the acquisition of a five-property portfolio in two tranches during the first half of 2025 and expects rent to commence on the new Beaumont facility lease in March or April 2025. The company remains well positioned to pursue additional opportunities that align with its target assets and return criteria.

Management Comments

  • Jeffrey M. Busch, Chairman, Chief Executive Officer and President stated, 'During the third quarter, we continued to deliver steady results while actively engaging in the transaction market to accretively grow our high-quality portfolio.'
  • Jeffrey M. Busch also stated, 'With ample liquidity, we remain well positioned in the market to continue to pursue additional opportunities that align with our target assets and return criteria.'

Industry Context

The announcement reflects the ongoing activity in the medical real estate sector, with REITs actively acquiring and disposing of properties to optimize their portfolios. The company's focus on single-tenant, triple-net leased medical facilities is a common strategy in the industry, providing stable income streams. The Steward Health Care bankruptcy highlights the risks associated with tenant concentration and the importance of diversification.

Comparison to Industry Standards

  • GMRE's portfolio occupancy of 96.1% is generally in line with industry averages for medical office REITs, which typically range from 90% to 98%.
  • The company's weighted average lease term of 5.6 years is comparable to other net-lease REITs, which often have lease terms between 5 and 10 years.
  • The rent coverage ratio of 4.6x is a positive indicator of tenant health and is generally considered healthy for medical office properties.
  • The company's leverage ratio of 44.1% is within the typical range for REITs, but it is important to monitor this metric closely.
  • The cap rate of 9.0% for the new acquisition is attractive in the current market, suggesting a good return on investment.
  • Compared to peers like Healthcare Realty Trust (HR) and Physicians Realty Trust (DOC), GMRE is smaller in terms of market capitalization but is actively growing its portfolio through acquisitions.
  • The company's focus on single-tenant, triple-net leases is similar to that of other medical REITs like National Health Investors (NHI) and Medical Properties Trust (MPW), but GMRE has a higher proportion of health system tenants.

Stakeholder Impact

  • Shareholders may be concerned about the decrease in net income, FFO, and AFFO.
  • Employees may be impacted by the company's performance and future growth plans.
  • Tenants may be affected by the company's acquisition and disposition activities.
  • Creditors may be interested in the company's debt levels and financial performance.

Next Steps

  • The company will complete the acquisition of the five-property portfolio in the first half of 2025.
  • The company will commence rent on the new lease at the Beaumont facility in March or April 2025.
  • The company will continue to pursue additional acquisition opportunities.
  • The company will host a live webcast and conference call on November 7, 2024, to discuss the results.

Key Dates

DateDescription
May 6, 2024Steward Health Care filed for Chapter 11 bankruptcy.
July 2024The company completed the acquisition of five properties in a 15-property portfolio for $30.8 million.
July 2024The company sold a medical facility in Panama City, Florida for $11.0 million.
September 5, 2024The Board of Directors declared a $0.21 per share cash dividend to common stockholders.
September 15, 2024Steward formally rejected its lease at the Beaumont Facility.
September 20, 2024Record date for the $0.21 per share cash dividend to common stockholders.
September 30, 2024End of the third quarter, financial results reported.
October 2, 2024The company completed the acquisition of the remaining 10 properties in the 15-property portfolio for $49.5 million.
October 8, 2024Payment date for the $0.21 per share cash dividend to common stockholders.
October 15, 2024Record date for the $0.46875 per share cash dividend to holders of Series A Preferred Stock.
October 29, 2024The company entered into a purchase agreement to acquire a five-property portfolio for $69.6 million.
October 31, 2024Payment date for the $0.46875 per share cash dividend to holders of Series A Preferred Stock.
November 5, 2024Date of the company's borrowing capacity under the credit facility was $221 million.
November 6, 2024Date of the 8-K filing and announcement of third quarter results.
November 7, 2024Date of the live webcast and conference call to discuss the results.
March or April 2025Expected rent commencement date for the new lease at the Beaumont Facility.
First half of 2025Expected completion of the acquisition of the five-property portfolio.

Keywords

Medical REIT, Real Estate Investment Trust, Healthcare Facilities, Net Lease, Acquisitions, Dispositions, FFO, AFFO, Occupancy, Rent Coverage, Debt, ATM Program

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.